Literature DB >> 33771497

Polycystic ovary syndrome and breast cancer subtypes: a Mendelian randomization study.

Tiantian Zhu1, Jinrui Cui1, Mark O Goodarzi2.   

Abstract

Entities:  

Year:  2021        PMID： 33771497     DOI： 10.1016/j.ajog.2021.03.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  3 in total

Review 1.  Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.

Authors:  Tiantian Zhu; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

Review 2.  The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis.

Authors:  Parisa Kohnepoushi; Hojat Dehghanbanadaki; Pardis Mohammadzedeh; Maziar Nikouei; Yousef Moradi
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

3.  Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.

Authors:  Jaakko S Tyrmi; Riikka K Arffman; Natàlia Pujol-Gualdo; Venla Kurra; Laure Morin-Papunen; Eeva Sliz; Terhi T Piltonen; Triin Laisk; Johannes Kettunen; Hannele Laivuori
Journal:  Hum Reprod       Date:  2022-01-28       Impact factor: 6.918
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.